Repligen Celebrates Advancements in Corporate Sustainability
Repligen Corporation (NASDAQ:RGEN), a prominent player in the bioprocessing technology sector, has recently unveiled its 2024 Corporate Sustainability Report. This digitally published report, themed "Perspectives on Progress", sheds light on the company’s ongoing commitment to enhancing sustainability across six critical areas, including Products & Packaging, Operations, Talent, Supply Chain, Communities, and Partnerships & Pathways.
The report is more than just a document; it includes disclosures that align with the United Nations Sustainable Development Goals (UN SDGs) and two pivotal reporting frameworks: the Global Reporting Initiative (GRI) Standards and the Sustainability Accounting Standards Board (SASB), now integrated into the IFRS Sustainability Alliance. By adopting these frameworks, Repligen demonstrates its dedication to transparency and accountability in sustainability practices.
Leadership Insights on Sustainability
Olivier Loeillot, President and Chief Executive Officer at Repligen, emphasizes the company's pragmatic approach towards sustainability. He believes that ongoing improvements in business practices are synonymous with sustainability itself. Loeillot's vision depicts sustainability not merely as an obligation but as an intrinsic part of business resilience.
Dianne Heiler, Vice President of Sustainability & ESG and Global Head of Packaging Engineering, reinforces this sentiment, stating that the current global events have catalyzed conversations around sustainable practices. Repligen’s consistent focus on sustainability reflects a value-driven strategy that not only aligns with corporate goals but also delivers tangible business value. This report acts as Repligen Corporation’s 2024 Communication on Progress in line with commitments to the United Nations Global Compact (UNGC).
Key Highlights from the 2024 Report
The 2024 Corporate Sustainability Report presents several noteworthy accomplishments that underline Repligen’s commitment to environmental, social, and governance priorities, with data reflecting achievements up until the close of 2024.
Advancing Impacts: Report Highlights
- Transition to 100% renewable electricity at all manufacturing sites, increasing from 13 to 19 sites, which equals 100% of global consumption.
- A remarkable 25% reduction in waste generation and a 32% decline in total waste intensity normalized to revenue, compared to the previous year.
- Expanded Scope 3 emissions inventory to include all relevant emissions categories, moving from 9 to 11 of 15 total categories.
- Participation in the UNGC Network USA Business and Human Rights Accelerator program, which aims to incorporate the UN Guiding Principles into corporate operations and sustainability strategy.
- Inaugurated the Repligen Training and Innovation Center (RTIC) in Waltham, MA, emphasizing customer engagement and education.
About Repligen Corporation
Repligen Corporation is recognized as a global life sciences company dedicated to developing and commercializing innovative bioprocessing technologies and systems that enhance efficiency in the manufacturing of biological drugs. Our goal is to inspire advances in bioprocessing for clients that primarily include biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide.
Specializing in areas like Filtration and Fluid Management, Chromatography, Process Analytics, and Proteins, Repligen’s corporate headquarters is situated in Waltham, Massachusetts, alongside numerous manufacturing locations across the U.S. and key sites spread over Estonia, France, Germany, Ireland, the Netherlands, and Sweden. To get more information, please visit www.repligen.com and engage with us on LinkedIn.
Frequently Asked Questions
What is the focus of Repligen's 2024 Corporate Sustainability Report?
The report emphasizes Repligen’s commitment to sustainability across various key impact areas such as operations, community engagement, and environmental initiatives.
How does Repligen align its practices with global standards?
Repligen utilizes the UN Sustainable Development Goals and reporting standards such as GRI and SASB to ensure comprehensive accountability in sustainability efforts.
What innovations are highlighted in the report?
The establishment of the Repligen Training and Innovation Center is a highlight, showcasing a commitment to client education and innovation in bioprocessing.
How is Repligen addressing waste reduction?
By achieving a 25% reduction in waste generation and 32% decrease in waste intensity normalized to revenue, Repligen showcases its dedication to minimizing environmental impact.
Who should be contacted for more information about Repligen?
For inquiries, Jacob Johnson, VP of Investor Relations, can be contacted at (781) 419-0204 or via email at investors@repligen.com.
